Abstract | BACKGROUND: METHODS: This retrospective, case-control study enrolled patients with ARDS admitted to the intensive care unit of a tertiary referral hospital between January 2007 and December 2012. Overall, 216 patients with ARDS-81 receiving ECMO (ECMO group) and 135 not receiving ECMO (non-ECMO group)-were enrolled in this study. Patients were paired when the difference in their APACHE II scores was within 3 points and their age difference was 3 years. In total, 126 patients could not be matched and were thus excluded. Eventually, of the 90 patients with ARDS enrolled in this study, 45 ECMO group patients were matched with 45 non-ECMO group patients. The demographic data, reasons for intensive care unit admission, and laboratory variables were evaluated. RESULTS: The primary etiology of ARDS was infection (72.2%). The APACHE II score and age-matched group receiving ECMO therapy had higher inhospital survival rates. Moreover, the patients receiving ECMO therapy had significantly lower 6-month mortality rates than did the non-ECMO group. CONCLUSIONS: Patients with ARDS who received ECMO treatment had higher inhospital survival rates than did those with a similar disease severity and at a similar age who did not receive ECMO.
|
Authors | Hsiao-Chi Tsai, Chih-Hsiang Chang, Feng-Chun Tsai, Pei-Chun Fan, Kuo-Chang Juan, Chan-Yu Lin, Huang-Yu Yang, Kuo-Chin Kao, Ji-Tseng Fang, Chih-Wei Yang, Su-Wei Chang, Yung-Chang Chen |
Journal | The Annals of thoracic surgery
(Ann Thorac Surg)
Vol. 100
Issue 2
Pg. 458-64
(Aug 2015)
ISSN: 1552-6259 [Electronic] Netherlands |
PMID | 26116481
(Publication Type: Journal Article)
|
Copyright | Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved. |
Topics |
- APACHE
- Case-Control Studies
- Extracorporeal Membrane Oxygenation
- Female
- Humans
- Male
- Middle Aged
- Prognosis
- Respiratory Distress Syndrome
(diagnosis, mortality, therapy)
- Retrospective Studies
- Survival Rate
- Treatment Outcome
|